C P Worman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C P Worman

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

Clinical and Laboratory Haematology|January 1, 1981

IgE lambda paraproteinaemia associated with a pleomorphic lymphoproliferative disorderD L Barnard, C P Worman, I Boldersen, et al.

Acta Haematologica|January 1, 1993

Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patientE N McSweeney, C P Worman, C P Tsakona, et al.

British Journal of Haematology|August 1, 1985

Interferon is effective in hairy-cell leukaemiaC P Worman, D Catovsky, P C Bevan, et al.

British Journal of Haematology|September 1, 1993

Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemiaE N McSweeney, F J Giles, C P Worman, et al.

Pageof 7

Search research articles

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

Clinical and Laboratory Haematology|January 1, 1981

IgE lambda paraproteinaemia associated with a pleomorphic lymphoproliferative disorderD L Barnard, C P Worman, I Boldersen, et al.

Acta Haematologica|January 1, 1993

Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patientE N McSweeney, C P Worman, C P Tsakona, et al.

British Journal of Haematology|August 1, 1985

Interferon is effective in hairy-cell leukaemiaC P Worman, D Catovsky, P C Bevan, et al.

British Journal of Haematology|September 1, 1993

Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemiaE N McSweeney, F J Giles, C P Worman, et al.

Pageof 7